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Abstract
Background: Despite vaccination since the 1950s, pertussis has persisted and resurged. It remains a m ajor cause o f 
in fan t death w o rld w id e  and is the  m ost prevalent vaccine-preventable disease in developed countries. The 
resurgence o f pertussis has been associated w ith  the expansion o f Bordetella pertussis strains w ith  a novel allele for 
the  pertussis tox in  (Ptx) prom oter, ptxP3, w hich have replaced resident ptxP1 strains. Com pared to  ptxP1 strains, 
ptxP3 produce m ore Ptx resulting in increased viru lence and im m une suppression. To elucidate ho w  B. pertussis has 
adapted to  vaccination, we com pared genom e sequences o f tw o  ptxP3 strains w ith  fou r strains isolated before and 
after the  in troduc tion  vaccination.
Results: The d is tribu tion  o f SNPs in regions involved in transcription and translation suggested tha t changes in 
gene regulation play an im portan t role in adaptation. No evidence was found  fo r acquisition o f novel genes. 
M odern strains d iffered sign ificantly from  prevaccination strains, bo th  phylogenetica lly  and w ith  respect to 
particular alleles. The ptxP3 strains were found  to  have diverged recently from  m odern p txP I strains. Differences 
betw een ptxP3  and m odern p txP I strains included SNPs in a num ber o f pathogenicity-associated genes. Further, 
bo th  gene inactivation and reactivation was observed in ptxP3 strains relative to  m odern p txP I strains.
Conclusions: Our w o rk  suggests tha t B. pertussis adapted by successive accum ulation o f SNPs and by gene (in) 
activation. In particular changes in gene regulation may have played a role in adaptation.
Background
The genus Bordetella comprises nine species, of which 
four are exclusively respiratory pathogens of mammalian 
hosts: Bordetella bronchiseptica, Bordetella parapertus­
sis, Bordetella pertussis and Bordetella holmesii [1]. The 
first three species are closely related, while B. holmesii 
forms a distinct branch [2]. B. bronchiseptica causes 
chronic and often asymptomatic respiratory tract infec­
tions in a wide variety of mammals and is only sporadi­
cally isolated from humans. B. parapertussis consists of 
two distinct lineages, designated B. parapertussisHU and 
B. parapertussisOV, which infect humans and sheep 
respectively [3,4]. B. parapertussisHU and B. pertussis are 
exclusive human pathogens and the causative agents of 
pertussis or whooping cough. Both these species have 
evolved independently from a B. bronchiseptica-like
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ancestor, a process which has been accompanied by 
extensive gene loss [4-6].
By far, most cases of whooping cough are caused by 
B. pertussis. Despite widespread vaccination, pertussis 
remains a major cause of infant death worldwide [7]. In 
the 1990s a resurgence of pertussis was observed in sev­
eral countries with highly vaccinated populations and 
pertussis has become the most prevalent vaccine- 
preventable disease in developed countries [8-10]. In the 
Netherlands, the estimated rate of infection was 6.6% per 
year for the 3-79-year age group from 1995 through 1996 
[11]. Similar percentages have been found in the United 
States [12-14]. One of the hallmarks of the pertussis 
resurgence is a shift in disease prevalence towards older 
persons who have waning vaccine-induced immunity, 
while recently vaccinated infants are well protected [15]. 
The reemergence of pertussis has been attributed to var­
ious factors including decreased vaccination coverage 
due to concerns over side effects, suboptimal vaccines, 
waning vaccine-induced immunity, and adaptation of
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B. pertussis [1,9,10]. The relative contribution of these 
factors may differ between countries and is the subject of 
ongoing debate. Pathogen adaptation is supported by sev­
eral observations. We and others have shown that anti­
genic divergence has occurred between vaccine strains 
and clinical isolates with respect to surface proteins 
which confer protective immunity; pertussis toxin (Ptx), 
pertactin and fimbriae [1,16-18]. Further, in a mouse 
model, pertussis vaccines were less effective against 
strains carrying non-vaccine type antigens compared to 
strains with vaccine-type antigens [19-22]. Recently we 
found evidence that polymorphism in the promoter for 
Ptx (ptxP) may also be important in adaptation [23]. In 
the last twenty years two ptxP  alleles, ptxP1 and ptxP3, 
predominated in the Dutch B. pertussis population. The 
ptxP3  strains were first observed in 1988, gradually 
increased in frequency, and nearly completely replaced 
the resident ptxP1 strains in the late 1990s. In the Neth­
erlands, the increase in frequency of ptxP3 strains was 
associated with the resurgence of pertussis. The ptxP3 
strains are found in Asia, Europe, North and South 
America, and there is evidence that they have spread 
worldwide in the 1980s and 1990s [23]. The ptxP3 strains 
produced more Ptx than the ptxP1 strain and epidemio­
logical data suggest that ptxP3 strains are more virulent. 
Ptx suppresses both the innate and adaptive immune sys­
tem [24,25] and we have proposed that increased Ptx 
production increases pathogen fitness in vaccinated 
populations by enhancing transmission by hosts in which 
vaccine immunity has waned. Thus, both antigenic diver­
gence and increased immune suppression in combination 
with waning immunity are likely to contribute to the per­
tussis resurgence [23]. Here we extend our studies on 
adaptation of B. pertussis using comparative genomics. 
We determined, annotated and compared genome 
sequences of six Dutch strains, two of which were iso­
lated before vaccination was introduced in 1953 and four 
modern strains, isolated approximately 50 years later. 
The modern strains carried either the ptxP1 allele or the 
ptxP3  allele, while the pre-vaccination strains carried 
ptxP1 or ptxP2. We identified novel polymorphisms in 
specific genes and gene categories which may play a role 
in the persistence and resurgence of pertussis in the face 
of intensive vaccination.
Results and Discussion
Strain selection
Our long term aim is to identify B. pertussis loci which 
have contributed to the persistence and resurgence of 
pertussis in vaccinated populations. We selected two 
strains isolated in 1949 and 1952 which were character­
istic for the Dutch B. pertussis population in the pre­
vaccine era [16,26], and four modern strains isolated in
1999 and 2000, approximately 50 years after the intro­
duction of vaccination. Two of the modern strains car­
ried the ptxP1 allele and two the ptxP3 allele. In our 
comparisons, we included the Tohama I strain (ptxP1) 
of which the annotated genome sequence was available 
[6]. The Tohama I strain was isolated in Japan in the 
1950s and has been subcultured in vitro extensively. It 
is used as model strain in many different laboratories. 
Strain characteristics are listed in Table 1.
Comparative analysis of Bordetella pertussis genomes
We determined the genome sequences of the six B. per­
tussis strains through pyrosequencing. As this technol­
ogy is known to generate errors in homopolymeric 
nucleotide tracts, SNPs and indels in these regions were 
filtered out. As a consequence, differences between 
strains in homopolymeric nucleotide tracts were not 
identified. However, homopolymeric nucleotide tracts 
have high mutation rates and may vary during subcul- 
turing of a single strain [27]. Thus, genotypes and phe­
notypes controlled by homopolymeric nucleotide tracts 
are not stable and changes in these tracts will not repre­
sent fixed differences between strains.
We identified 471 SNPs (i.e. bases that were not con­
served in one or more of the seven strains), of which 
414 and 57 were located in ORFs and intergenic regions, 
respectively (Additional file 1). Four ORFs were found to 
contain small insertion or deletions (indels) ranging 
from eight to 31 bases (Additional file 1). Based on our 
analyses, the estimated SNP density was 1 SNP per 
8,675 bases. Maharjan and coworkers used Microarray- 
based comparative genome sequencing to detect SNPs 
in 34% of the Tohama I genome [28]. The Tohama I 
strain was compared to an Australian isolate from 2006 
and a SNP density of 1 SNP per 20,000 bases was 
found. As we included the whole genome in our com­
parison and used a larger number of strains, the higher 
SNP density we found was not unexpected. SNP densi­
ties in other monomorphic human pathogens have been 
found to range from 1 SNP per 2,300 bases in Salmo­
nella enterica serovar Typhi [29] to 1 SNP per 28,400 
bases in M ycobacterium leprae [30,28]. This places 
B. pertussis among the most monomorphic human 
pathogens known. In their analyses, Maharjan and cow­
orkers identified 66 SNPs in 1,229 genes and 4 SNPs in 
268 intergenic regions. Of these 70 SNPs, 27 (39%) were 
also detected in one of the six Dutch strains, while 14 
(20%) were specific for the Australian strain.
In addition to the SNPs discussed above, we con­
firmed 13 large regions of difference (RDs) identified in 
previous studies using microarrays [31-35] and whole 
genome sequencing [33,36]. Further, we found a new 
polymorphism in RD23 (Additional files 2 and 3).
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Table 1 Isolates used in this study1
Isolate Coverage Genome size (Mb) C ountry Year Sero type ptxP ptxA prn fim 2 fim 3 Ref
Tohama I NA 4,09 Japan 1952 2 ptxP1 ptxA2 prn1 fim2-1 fim3-1 [6]
B0558 16x 4,12 Netherlands 1949 3 ptxP1 ptxA2 prn1 fim2-1 fim3-1 this work
B1193 15x 4,12 Netherlands 1950 2,3 ptxP2 ptxA4 prn7 fim2-2 fim3-1 this work
B1831 28x 4,08 Netherlands 1999 3 ptxP3 ptxA1 prn2 fim2-1 fim3-2 this work
B1834 28x 4,08 Netherlands 1999 3 ptxP1 ptxA1 prn2 fim2-1 fim3-1 this work
B1917 15x 4,08 Netherlands 2000 3 ptxP3 ptxA1 prn2 fim2-1 fim3-2 this work
B1920 15x 4,08 Netherlands 2000 3 ptxP1 ptxA1 prn2 fim2-1 fim3-1 this work
1 Year of isolation and alleles of main virulence factors are shown. Coverage refers to oversampling in sequence data. Genome size was based on size of the 
Tohama I genome corrected for the large regions of differences. Abbreviations: Mb, megabases; NA not available.
Genetic relationship based on whole genome sequencing
A maximum likelihood phylogenetic tree based on 471 
SNPs was derived (Figure 1). The genome sequence of B. 
bronchiseptica was used as outgroup to root the tree [6]. 
The tree suggested that B1193, which harbors the ptxP2 
allele, represented a distinct lineage which diverged from 
the six other strains relatively early in the history of B. per­
tussis. Although the Tohama I strain was more closely 
related to the four remaining Dutch strains, it also formed 
a distinct, relatively deep branch. This may be due to the 
fact that the Tohama I strain has been subcultured in vitro 
since the 1950s resulting in a relaxation of selective forces, 
or it could reflect geographical isolation, as the Tohama I 
strains was isolated in Japan, while all other strains were 
from the Netherlands. The four recently isolated Dutch 
strains were closely related. The tree indicated that the 
ptxP3  strains comprise a monophyletic lineage which 
recently diverged from modern ptxP1 strains.
Evidence for selection in cis regulatory regions
Although it is often assumed that mutations located 
outside protein coding sequences (CDSs) are neutral,
such mutations can affect fitness if they are located in 
cis-regulatory elements (i.e. in regions involved in bind­
ing of transcriptional factors or in regions that affect 
translation). To explore the role of cis regulatory ele­
ments in adaptation, we determined the distribution of 
all SNPs in intergenic regions relative to the start codon 
of predicted CDSs in segments of 25 bases (Figure 2). 
Assuming random mutation (the null hypothesis), one 
expects a SNP distribution which reflects the frequency 
of the 25 base intergenic segments in the chromosome. 
This frequency is highest for the proximate 25 base seg­
ment and decreases with distance to the start codon 
(Figure 2). The actual frequency distribution was com­
pared with the frequency based on null hypothesis and 
found to be significantly different (P 0.01). In view of 
the low number of SNPs observed, the region 200 to > 
500 will be ignored. In the regions 50-99 and 175-199 
more SNPs were observed than in the random mutation 
model, suggesting diversifying selection. These regions 
may contain binding sites for regulatory proteins such 
as BvgA, as shown for Ptx [37]. The regions 125-174 
and 0-24 contained less SNPs compared to the random
B1193
B1917
B1831
B1834 Tohama I
B1920
F igure  1 P hylogenetic tree o f stra ins used in th is  s tudy based on 471 SNPs. Colored strain designations indicate ptxP alleles: black, ptxP1; 
blue, ptxP2; red, ptxP3. The location o f the root was based on the sequence o f B. bronchiseptica RB50 strain [6].
Bart et al. BMC Genomics 2010, 11:627
http://www.biom edcentra l.com /1471-2164/11/627
Page 4 o f 10
F igure 2 D is tribu tion  o f SNPs in in te rgen ic  regions re la tive to  the  s ta rt codons o f pred ic ted p ro te in  cod ing genes. The number o f SNPs 
was plotted as a function o f the distance to the initiation codon of genes using a w indow o f 25 bases. Blue columns show the expected 
distribution based on the frequency distribution o f 25 bases segments in intergenic regions. Red columns show the actual distribution. The two 
distributions are significantly different (Chi-square test, P 0.01).
model, possibly reflecting purifying selection. The region 
0-24 contains the binding site for RNA-polymerase and 
regions involved in initiation of translation and it seems 
that such regions tend to be conserved in B. pertussis. 
Thus our results provide evidence that regions involved 
in binding of regulatory proteins are subject to diversify­
ing selection suggesting a role in adaptation. The low 
degree of polymorphism, the limited number of strains 
sequenced and the absence of silent mutations in some 
CDSs did not allow calculation of dN/dS ratios to iden­
tify purifying or diversifying selection in ORFs [38-40].
Polymorphisms in pathogenicity-associated genes
The 89 pathogenicity-associated genes (Additional file 4) 
contained 34 polymorphisms (SNPs and small indels) 
distributed over 24 genes and three promoter regions 
(Figure 3 and Additional file 5). To the best of our 
knowledge, 16 of the polymorphisms in pathogenicity- 
associated genes were not described before. Nineteen of 
the 34 polymorphisms were specific for the ptxP2 strain, 
again underlining the distinct nature of this strain. It 
was noteworthy that for Ptx, Prn (unpublished data), the
type III secretion toxin (BteA) and tracheal colonization 
factor (TcfA), polymorphisms were found in both the 
protein coding sequences [41,42] and the (putative) pro­
moter regions, suggesting both structural and regulatory 
adaptations for these virulence factors.
Polymorphisms which distinguish strains isolated before 
and after the introduction of vaccination
The comparison of polymorphisms which distinguish 
strains isolated before and after the introduction of vac­
cination (for convenience designated as pre- and post­
strains) may be useful to identify mutations which 
increase fitness in vaccinated populations and hence 
reduce vaccine efficacy. We identified 14 non-silent, 11 
silent SNPs, three intergenic SNPs, one nonsense muta­
tion and two indels which distinguished pre- and post­
strains (pseudo-genes were excluded). The distribution 
of alleles and SNPs are shown in Additional file 6 and 
Figure 4, respectively. Here, only polymorphisms 
believed to be particularly interesting based on our cur­
rent knowledge are discussed. The post-strains were dis­
tinguished by a large deletion (RD3) comprising
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24 CDSs. King et al. [34] analyzed a larger number of 
post-strains (N = 43), all of which were found to miss 
RD3. RD3 contains four ORFs coding for putative 
exported proteins and its removal may reduce the anti­
genic profile of B. pertussis. Alternatively, the deletion of
this region may be unrelated to vaccination and reflect 
the ongoing genome reduction [32,35]. One gene, pitA  
coding for a putative phosphate transporter, was inacti­
vated in post-strains by a nonsense mutation. The non­
sense mutation was also observed in an Australian
pre post
gene locus
position In 
Tohama 1
type of 
polymorphism To
ha
m
i
B
11
93 aainino
ID B
18
34
B
19
20
B1
83
1
B
19
17
(putative) product or function reference
BP0191 193157 silent putative exported protein This w ork
ppc BP0215 220937 silent phosphoenol pyruvate carboxylase This work, 28
btcAP/btcEP BP0499P/BP0500P 511992 intergenic promoter outer m em brane heme receptor /  promotor hypothetical proteii This w ork
BP0505 517207 silent phage-related conserved hypothetical proteir This w ork
BP0518 525420 non-silent conserved hypothetical proteir This w ork
nuoN BP0854 883816 non-silent NADH-ubiquinone oxidoredudase, chain N This w ork
pphA BP0904 939561 non-silent serlne/threonlne protein phosphatase 1 This w ork
pitA BP1014 1059382 nonsense probable phosphate transportei This work, 28
pm BP1054 1098916..1098930 Indel pertactln precursor This work, 16,55,56,57
BP1090 1137841 non-silent conserved hypothetical proteir This w ork
rndA BP1227 1290405 silent DNA repair protein This w ork
BP1542 1615665 non-silent conserved hypothetical proteir This work, 28
dapA BP1570 1649623 non-sllent dihydrodipicolinate synthase This work. 28
BP1722 1806314 non-silent conserved hypothetical proteir This w ork
BP1838P/BP1839P 1931433 Intergenic promotor putative exported protein / promotor 30S  ribosomal protein S1( This w ork
BP2028 2141172 non-silent putative exported protein This w ork
BP2075 2194726 silent putative efflux system inner mem brane proteir This w ork
BP2271 2392797 non-silent putative regulatory lipoproteir This w ork
BP2348 2488085 silent putative polyamine transport proteir This w ork
BP2585 2736088 silent DedA-fam ily integral mem brane proteir This work, 28
BP2713 2879950 silent putative hydrolase This work, 28
BP2935 3123720 non-silent putative two com ponent system, histidine kinasi This work, 28
BP2974P/BP2975P 3161770 intergenic transcriptional regulatoi This w ork
cca BP3059 3260282 silent tRNA nucleotidyltransferase This work, 28
rpoA BP3642 3846833 silent DNA-directed RNA polymerase a lpha chain This w ork
rkpK BP3728 3938341 non-silent putative UDP-glucose 6-dehydrogenase This work, 28
ptxA BP3783 3988941 non-silent pertussis toxin subunit 1 precuraoi This work, 28
BP3857 4068047 non-silent putative hydrolase This w ork
BP3858 4068650 non-silent putative transport A TP-binding proteir This w ork
BP3861 4071996 silent putative transport system permease proteir This work. 28
BP0911-BP0934 indel RD3 (see Additional file 3) This work, 59
F igu re  4 Polym orph ism s w h ich  d is ting u ish  stra ins iso lated be fore (pre) and a fte r (post) the  in tro d u c tio n  o f vaccina tion. W ithin rows, 
polymorphisms are distinguished by color. Genes truncated in all strains were omitted. An overview o f alleles is given in Additiona lfile  6. 
Abbreviation: indel, insertion/deletion. Ps, pseudogene. References [16,28,55-57,59].
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strain [28]. Post-strain-specific, non-silent, polymorph­
isms were found in two genes for exported virulence 
factors, prn and ptxA, in agreement with previous stu­
dies [18]. There is evidence that polymorphism in these 
two genes affects vaccine efficacy in a mouse model 
[19-22]. The locus for another (putative) exported pro­
tein (BP2028) also contained a non-silent polymorphism 
specific for post-strains. Blast searches revealed 100% 
identity at the amino acid level between the prevaccina­
tion variant and homologues found in B. bronchiseptica 
and B. parapertussis, suggesting that the prevaccination 
strains harbor the ancestral allele. No significant similar­
ity was found with CDSs from other bacteria, suggesting 
a highly specific function. Although the function of the 
protein is not known, the fact that it is exported sug­
gests a role in host-pathogen interaction. Also of inter­
est is a SNP in the promoter region for the type III 
secretion toxin and chaperone genes, bteA and btcA 
respectively. For B. bronchiseptica it has been shown 
that BteA is translocated into the host and is necessary 
and sufficient for rapid cytotoxicity in a wide range of 
mammalian cells [43,44]. The SNP, which involves an 
A/G transition, is located in a putative TATA box of 
btcA and therefore could influence its expression. We 
investigated the temporal trends of the two alleles, 
designated allele A and allele G (Figure 5). Allele A was 
found in all strains from 1949 to 1970 (N = 12). Allele 
G was first observed in 1977 and gradually increased in 
frequency to ~90% in 2000-2008. The allele A was 
found in B. bronchiseptica suggesting that it is the 
ancestral type, consistent with the trend observed in the 
Netherlands.
Polymorphisms which distinguish ptxP3 strains
Strains carrying the ptxP3 allele have spread worldwide 
and have contributed to the pertussis epidemic in The 
Netherlands [23]. It seems likely that the ptxP3 allele 
confers increased fitness compared to the ptxP1 allele it 
replaced in current human populations. Alternatively, it 
may be a marker for other selective changes in the same 
haplotype. To identify other genes that may have con­
tributed to the increased fitness of the ptxP3 lineage, we 
sought polymorphisms which were unique for the ptxP3 
lineage. We identified 26 polymorphisms specific for 
one or both ptxP3 strains, 11 non-silent SNPs, eight 
silent SNPs, four intergenic SNPs, two small indels 
(eight and 31 bases) and one large deletion (RD10, com­
prising 2.2 kbases). The distribution of alleles and poly­
morphisms are shown in Additional file 7 and Figure 6, 
respectively. Only polymorphisms we believe to be parti­
cularly interesting based on our current knowledge are 
discussed. The association of the RD10 deletion with 
ptxP3 strains was noted before using a larger collection 
of strains (N = 15) [34]. One of the intergenic SNPs was 
located in the ptx  promoter and defines the ptxP3 line­
age. The remaining three intergenic SNPs were located 
proximal to the genes for glycyl tRNA synthetase alpha 
chain gene (glyQ), a transporter, an integral membrane 
transport protein and a dihydrodipicolinate synthetase. 
It is not clear whether these SNPs affect transcription. 
We have shown previously that the SNP in the Ptx pro­
moter region affects production of Ptx, however [23]. 
Two ptxP3-specific SNPs were in known virulence 
genes, fim 3  and bscl, coding for the serotype 3 fimbriae 
and a component of the type III secretion system,
1949 -1 970  1971 -1 980  1981 -1 990  1991 -2 000  2000-2008  
Figure 5 Tem poral trend  in the  frequency o f a SNP located in the  p rom o te r reg ion fo r the  type  III secretion system. The SNP involved 
an A/G transition and was located between the type III secretion toxin gene bteA and its chaperone btcA. The two genes are oriented back to 
back. The period 1949-2008 was investigated using 44 strains.
v________________________________________________________________________________________________________________________________ y
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gene
position in 
Tohama I
ptxP  allele
type of polymorphism
promotor region BP0032P/BP0033P 36857 intergenic
. BP0184 185405 silent
- BP0194 196307 non-silent
- BP0369 370470 non-silent
- BP0418 419085 silent
■ BP0507 518837 silent
- BP0622 629247 silent
prfA BP0678 694521 silent
- BP0880 919028..919040 indel
cusC BP0986 1026448 non-silent
phoT BP1068 1114911 non-silent
- BP1471 1547488 non-silent
fim3 BP1568 1647861 non-silent
- BP1862 1952902 non-silent
bscl BP2249 2374322 non-silent
■ BP2428 2571837 non-silent
- BP2502 2651008 non-silent
- BP2946 3134411..3134461 indel
- BP3015 3207058 silent
- BP3062P 3263622 intergenic
rpsH BP3630 3840411 silent
promotor region BP3687P 3896353 intergenic
ptxP BP3783P 3988168 intergenic
ptxC BP3787 3991376 silent
- BP3825 4033170 non-silent
- BP1948-BP1966 2050602..2072505 indel
*-
s
Q.
3s
a
;  »  5  o  
F  i o  n  cm
m in  00 O) 
£  O  ^  ^
« -  f»  
2 5
O CD CO CO m  m
(putative) product or function
promotor region transporter /  promotor glycyl-tRNA 
synthetase alpha chain 
]  exp o rte d  pro te in  
]  metal transporter 
]  e n d o n u c le a se  
exp o rte d  pro te in  
|  hypothetical protein 
]leu/ile /val-b inding protein precursor 
]  peptide chain release factor 1 
]  exported protein 
|  outer membrane lipoprotein 
phosphate transport ATP-binding protein 
]  conserved hypothetical protein 
]  serotype 3 fimbriai subunit precursor 
membrane protein 
] ty p e  III secretion protein 
|  LysR-family transcriptional regulator 
|  hypothetical protein 
|  arsR-family transcriptional regulator 
peptidase fam ily M23/M37 protein 
|  promotor region membrane transport protein 
]  30S ribosomal protein S8 
|  promotor region dihydrodipicolinate synthase 
|  promotor region pertussis toxin subunit 1 precursor 
|  pertussis toxin subunit 3 precursor 
|  glycerol kinase 
]  RD10 (see Additional file 5)
F ig u re  6  P o ly m o rp h is m s  a ssoc ia te d  w ith  p tx P 3  s tra ins . The d is trib u tio n  o f po lym orphism s over the  analyzed strains is shown. W ith in  rows, 
polym orphism s are d istinguished by color. Genes truncated in all strains w ere om itted . An overview  o f all know n alleles is g iven in A dd itional 
file  7. Abbreviation: indel, insertion /de le tion; ps, pseudogene.
respectively [43,45]. Two indels, located in BP0880 and 
BP2946, were ptxP3-specific. BP0880 codes for a puta­
tive exported protein which shows similarity with metal 
dependent phosphohydrolases and signal transduction 
proteins, while the BP2496 product belongs to the 
family of arsS transcriptional regulators. BP0880 was a 
pseudogene in all strains, except the two ptxP3 strains 
in which the reading frame was restored by deletion of 
an eight base repeat. Conversely, the reading frame of 
arsS  was intact in all strains except the two ptxP3  
strains, due to the deletion of a 31 base repeat. Both 
BP0880 and BP2496 are intact in B. bronchiseptica and
B. parapertussis. The BP0880 and BP2496 genes from 
three ptxP3 strains were sequenced completely and the 
ORFs were found to be intact and truncated, respec­
tively. It seems likely that BP0880 and BP2946 are sub­
ject to phase variation, i.e. the reversible on/off 
switching of genes by varying DNA sequence repeat 
units [46]. Phase variation has been observed for a num­
ber of other B. pertussis genes [27,45,47]. Based on the 
phylogenetic relationships, it seems likely that BP0880 
and BP2949 were, respectively, reactivated and inacti­
vated in the ptxP3 lineage. This qualifies these loci for 
further analyses as to their role in the emergence of 
ptxP3 strains.
Conclusions
We provide the first comprehensive genomic compari­
son of a bacterial pathogen circulating in a highly vacci­
nated population. In this study, we included two strains 
from the prevaccination era and four strains isolated 
~50 years later. We confirmed and extended the obser­
vation that modern B. pertussis strains differed signifi­
cantly from prevaccination strains, both phylogenetically 
and with respect to particular alleles [1]. Further, we 
identified one highly divergent, possibly ancient, B. per­
tussis lineage, characterized by the ptxP 2  allele. Our 
work confirmed that B. pertussis strains differ signifi­
cantly in gene content due to gene loss, a process which 
may still be ongoing [32,35]. Further, we found no evi­
dence that acquisition of novel genes has played a role 
in adaptation, as has been suggested for B. holmesii [2]. 
In contrast, B. pertussis seems to adapt mainly by the 
successive accumulation of SNPs. Our work shows that, 
based on SNP density, B. pertussis is one of the most 
monomorphic human pathogens. This suggests a recent 
origin of this species or, more likely, a recent population 
bottle neck [1,4].
Our results provide evidence that regions involved in 
binding of regulatory proteins are subject to diversifying 
selection suggesting a role in adaptation. Indeed, this is
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exemplified by the rapid emergence of ptxP3 strains with 
increased pertussis toxin production [23]. A number of 
recent studies have highlighted the importance of changes 
in gene regulation in adaptation of pathogens [48-51]. It is 
noteworthy that for a number of virulence factors (Ptx, 
Prn and TcfA), SNPs were found in both the protein­
encoding genes and the (putative) promoter regions, sug­
gesting adaptation at both the structural and regulatory 
level for the same phenotype. Of interest is a SNP in the 
promoter region for the type III secretion toxin (BteA) 
and chaperone genes (BtcA). For B. bronchiseptica it has 
been shown that BteA is necessary and sufficient for rapid 
cytotoxicity in a wide range of mammalian cells [43,44]. 
The ancestral allele was found in all strains from before 
1977, but subsequently replaced by a novel allele which 
increased in frequency to ~90% in 2000-2008. This sug­
gests that the novel allele may significantly affect strain fit­
ness, although it is also possible that its increase in 
frequency is due to hitchhiking with other loci which 
affect fitness. In any case, this allele may be an important 
marker for successful lineages. The ptxP3 lineage, asso­
ciated with the resurgence of pertussis in the Netherlands, 
has emerged recently and spread worldwide [23]. We 
found that the ptxP3  strains comprised a young branch 
which diverged recently from modern ptxP1 strains. 
Several alleles were identified, which were uniquely asso­
ciated with the ptxP3 lineage and may thus have contribu­
ted to its success. Two ptxP3-specific  SNPs were in 
known virulence genes, fim3 and bscI, coding for the sero­
type 3 fimbriae and a component of the type III toxin 
secretion system, respectively. We also observed both 
reactivation and inactivation of genes in the ptxP3 lineage. 
In conclusion, this work has identified a number of genetic 
loci which are associated with highly successful strains. 
Further analyses of these loci can contribute to our under­
standing of the evolution of bacterial pathogens.
Methods
Strain, culture conditions and DNA isolation
The six clinical isolates used in this study are described 
in Table 1. Strains were grown on Bordet Gengou (BG) 
agar supplemented with 15% sheep blood and incubated 
for 3 days at 35°C. DNA was isolated using QIAGEN 
Genomic-tip 100/G kit, according to the manufacturer's 
instructions.
Genome sequencing and detection of polymorphisms
B1831 was sequenced using the 454 GS-G20 sequencer 
(Roche) and the other five isolates were sequenced using 
the 454 GS-FLX sequencer (Roche), according to the 
manufacturer's instructions. The generated reads were 
assembled de novo into contigs using the Newbler 
assembler (Roche).
SNPs, insertions and deletions were detected by map­
ping the contigs to the previously sequenced and anno­
tated B. pertussis Tohama I genome [6] using BLAST. 
We filtered SNP calls as described in [29]. Briefly, SNPs 
with low base quality, SNPs within 15 base of the end of 
a contig, SNPs in repetitive sequences, such as insertion 
sequence elements, and SNPs in homopolymeric tracts 
were removed. Single base insertions or deletions in 
homopolymeric tracts were ignored as these are often a 
result of 454 sequencing errors [52]. To determine the 
accuracy of these SNPs we verified 88 SNPs in the 
sequenced strains by combining PCR with mass spectro­
metry (Sequenom). All 88 SNPs were correct. Only for a 
subset of small indels (> 6 b), which distinguished sets 
of strains, were checked by resequencing and included 
in the analyses. Genome sequences have been submitted 
to the NCBI Nucleotide Sequence data base (accessions 
numbers; strain B0558, ADKR00000000; strain B1193, 
ADKS00000000; strain B1831, ADKT00000000; strain 
B1834, ADKU00000000; strain B1917, ADKV00000000; 
strain B1920, ADKW00000000).
Phylogenetic analysis
Only SNPs for which the allele at the orthologous 
nucleotide was determined in all strains were included 
in the phylogenetic analysis. A Maximum Likelihood 
tree was derived using PhyML [53] with the following 
parameters: model, HKY; transition/transversion ratio; 
estimated; proportion of invariable sites, estimated; 
number of relative substitution rate categories, 4; 
gamma distribution parameter, estimated; starting tree, 
BIONJ; optimize tree topology, yes; optimize branch 
lengths and rate parameters, yes.
Statistical analyses
To determine if there is evidence for selection in cis- 
regulatory loci, we compared the expected distribution 
of the distance of SNPs to the start of the gene with the 
actual distribution of these distances using the Chi 
square test. This was done for all genes.
Additional material
A d d itio n a l f ile  1: Supplem enta ry tab le  S1A &  S1B &  S1C.xlsx.
Contains a list o f SNPs, small insertions and deletions found in the 
analyzed genomes.
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